Nakajo M, Shapiro B, Copp J, Kalff V, Gross M D, Sisson J C, Beierwaltes W H
J Nucl Med. 1983 Aug;24(8):672-82.
The scintigraphic distribution of m-[131I]iodobenzylguanidine (I-131 MIBG), an adrenal medullary imaging agent, was studied to determine the patterns of uptake of this agent in man. The normal distribution of I-131 MIBG includes clear portrayal of the salivary glands, liver, spleen, and urinary bladder. The heart, middle and lower lung zones, and colon were less frequently or less clearly seen. The upper lung zones and kidneys were seldom visualized. The thyroid appeared only in cases of inadequate thyroidal blockade. The "normal" adrenal glands were seldom seen and faintly imaged in 2% at 24 hr after injection and in 16% at 48 hr, in patients shown not to have pheochromocytomas, whereas intra-adrenal, extraadrenal, and malignant pheochromocytomas usually appeared as intense focal areas of I-131 MIBG uptake at 24 through 72 hr.
研究了肾上腺髓质显像剂间位-[¹³¹I]碘苄胍(I-131 MIBG)的闪烁显像分布,以确定该药物在人体内的摄取模式。I-131 MIBG的正常分布包括清晰显示唾液腺、肝脏、脾脏和膀胱。心脏、肺中下部区域和结肠较少见或显示不清晰。肺上部区域和肾脏很少显影。仅在甲状腺阻滞不足的情况下甲状腺才显影。在无嗜铬细胞瘤的患者中,“正常”肾上腺很少见,注射后24小时2%的患者肾上腺显影模糊,48小时为16%;而肾上腺内、肾上腺外和恶性嗜铬细胞瘤通常在24至72小时表现为I-131 MIBG摄取的强烈局灶性区域。